According to a new market research report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022" published by MarketsandMarkets™, the global Radiotherapy Market is projected to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a CAGR of 6.8%.
Browse 116 market data tables and 36 figures spread through 222 pages and in-depth TOC on "Radiotherapy Market".
http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Ad Statistics
Times Displayed: 3899
Times Visited: 9 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
Early buyers will receive 10% customization on this report
Technological advancements in radiotherapy systems, increasing incidence and prevalence of cancer, rising geriatric population, and growing adoption of radiotherapy devices and procedures are the major factors driving market growth.
By type, the external beam radiotherapy segment is held the largest market share in 2016
Based on type, the external beam radiotherapy segment accounted for the largest share of the market. Rising adoption of linear accelerators for the treatment of cancer and development of advanced radiotherapy technologies are the key factors driving the growth of the external beam Radiotherapy Market segment.
By product type, the external beam radiotherapy segment is expected to grow at the highest CAGR
On the basis of product type, the Radiotherapy Market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy. In 2016, the external beam radiotherapy segment accounted for the largest market share and is expected to grow at the highest CAGR. The large share of this segment can primarily be attributed to factors such as growing prevalence of cancer, product enhancements, and increasing adoption of external beam radiotherapy devices in emerging countries.
North America dominated the market in 2016
Geographically, the Radiotherapy Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe. A number of factors such as technological advancements in radiotherapy equipment, growing number of cancer cases, and rising focus of key players on expanding their presence in North America are driving the growth of the Radiotherapy Market in this region.
